Oncology & Cancer
New drug extends advanced lung cancer survival
A new drug can help advanced lung cancer patients live longer and may aid in treating other kinds of cancer, researchers said Monday.
Jun 3, 2013
0
0
Page 36 - News tagged with cancer therapeutics
Medical research
Compression of cancer cells is a double-edged sword, study finds
Adhering closely to Darwin's theory of evolution, tumors need to adapt to environmental changes to survive. A new study shows that one of those changes—the compression of cells—can both help and hinder the progression ...
Sep 25, 2023
0
51
Oncology & Cancer
Physical activity benefits lung cancer patients and survivors
Exercise and physical activity should be considered as therapeutic options for lung cancer as they have been shown to reduce symptoms, increase exercise tolerance, improve quality of life, and potentially reduce length of ...
Apr 2, 2015
0
42
Oncology & Cancer
Researchers develop non-invasive technique for predicting patients' response to chemotherapy
Researchers have developed a non-invasive way of predicting how much of a cancer-killing drug is absorbed by a tumour. The preliminary study, which will be reported at the 24th EORTC-NCI-AACR Symposium on Molecular Targets ...
Nov 7, 2012
0
0
Oncology & Cancer
Pathway identified in human lymphoma points way to new blood cancer treatments
A pathway called the "Unfolded Protein Response," or UPR, a cell's way of responding to unfolded and misfolded proteins, helps tumor cells escape programmed cell death during the development of lymphoma.
Nov 21, 2012
0
0
Oncology & Cancer
Preclinical data support ongoing clinical trials testing IDO inhibitors as a treatment for cancer
Inhibitors of indoleamine 2,3-dioxygenase (IDO) are being assessed in clinical trials as a potential treatment for recurrent or refractory solid tumors. Clear genetic rationale for these trials, together with evidence that ...
Jul 19, 2012
0
0
Oncology & Cancer
Subcutaneous administration of multispecific antibody makes tumor treatment faster and more tolerable
Tumor treatment with multispecific antibodies is significantly more tolerable if administered subcutaneously rather than via the bloodstream, which was the standard procedure until now. This was the result of an animal model ...
Jul 1, 2015
0
19
Oncology & Cancer
Reducing breast cancer metastasis in animal models by modifying tumor electrical properties
In normal cells, electrical voltage patterns provide a blueprint for orderly growth. But with cancer, the opposite happens. Marked by a breakdown in the normal electrical patterns generated by the cells, they lose their specialized ...
Jan 11, 2022
0
7
Oncology & Cancer
Targeting microRNA may benefit some ovarian and breast cancer patients
A genetic misfire called the 3q26.2 amplicon can cause real havoc. In fact, it is among the most frequent chromosomal aberrations seen in many cancers, including ovarian and breast cancers.
Dec 8, 2014
0
0
Oncology & Cancer
Research shows early promise of new drug for cancers caused by viruses
Christopher Parsons, MD, Director of the HIV Malignancies Program at LSU Health Sciences Center New Orleans, is the senior author of a paper that is the first to report that specialized fat (lipid) molecules, called sphingolipids, ...
Jan 14, 2014
0
0
